CS Diagnostics Corp. (CSDX)
OTCMKTS · Delayed Price · Currency is USD
0.138
+0.008 (6.15%)
At close: Apr 28, 2026

CS Diagnostics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2009 FY 2008 2007 - 2003
Period Ending
Dec '25 Dec '24 Dec '23 Dec '09 Dec '08 2007 - 2003
Operating Revenue
--0.13--
Upgrade
Other Revenue
0.20.11---
Upgrade
Revenue
0.20.110.13--
Upgrade
Revenue Growth (YoY)
83.93%-12.00%---
Upgrade
Gross Profit
0.20.110.13--
Upgrade
Selling, General & Admin
0.130.110.150.230.36
Upgrade
Operating Expenses
0.130.110.150.230.36
Upgrade
Operating Income
0.070-0.02-0.23-0.36
Upgrade
Other Non Operating Income (Expenses)
----0.04-0.05
Upgrade
Pretax Income
0.070-0.02-0.27-0.4
Upgrade
Net Income
0.070-0.02-0.27-0.4
Upgrade
Net Income to Common
0.070-0.02-0.27-0.4
Upgrade
Net Income Growth
9258.61%----
Upgrade
Shares Outstanding (Basic)
25013711100
Upgrade
Shares Outstanding (Diluted)
25013711100
Upgrade
Shares Change (YoY)
82.09%23.92%114621.71%--
Upgrade
EPS (Basic)
0.000.00-0.00-2.79-4.16
Upgrade
EPS (Diluted)
0.000.00-0.00-2.79-4.16
Upgrade
EPS Growth
5580.00%----
Upgrade
Free Cash Flow
0.010.010.01-0-0.74
Upgrade
Free Cash Flow Per Share
----0.00-7.69
Upgrade
Gross Margin
100.00%100.00%100.00%--
Upgrade
Operating Margin
34.91%0.69%-17.45%--
Upgrade
Profit Margin
34.91%0.69%-17.45%--
Upgrade
Free Cash Flow Margin
3.09%9.95%7.37%--
Upgrade
EBITDA
----0.23-0.35
Upgrade
D&A For EBITDA
---00
Upgrade
EBIT
0.070-0.02-0.23-0.36
Upgrade
EBIT Margin
34.91%0.69%-17.45%--
Upgrade
Revenue as Reported
0.20.110.13--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.